Genaissance Pharmaceuticals, Inc. Lock-Up Agreement December 18, 2003Genaissance Pharmaceuticals Inc • December 24th, 2003 • Services-commercial physical & biological research
The undersigned understands that Genaissance Pharmaceuticals, Inc., a Delaware corporation (the "Buyer"), Brown Acquisition Corp., a Delaware corporation and a wholly owned subsidiary of the Buyer (the "Transitory Subsidiary"), and Lark Technologies, Inc., a Delaware corporation, including any foreign branch, division or operating unit (collectively, the "Company"), have, concurrently with the execution of this Lock-Up Agreement (the "Lock-Up Agreement"), entered into an Agreement and Plan of Merger of even date herewith (the "Merger Agreement"), and that as a condition to the willingness of Buyer to enter into such Merger Agreement, Buyer has required the undersigned, and in order to induce Buyer to enter into the Merger Agreement, the undersigned is willing to enter into this Lock-Up Agreement.
COMPANY STOCKHOLDER AGREEMENTCompany Stockholder Agreement • December 24th, 2003 • Genaissance Pharmaceuticals Inc • Services-commercial physical & biological research • Delaware
THIS STOCKHOLDER AGREEMENT, dated as of December 18, 2003 (this "Agreement"), among the stockholders listed on the signature page(s) hereto (collectively, "Stockholders" and each individually, a "Stockholder"), Lark Technologies, Inc., a Delaware corporation (the "Company"), and Genaissance Pharmaceuticals, Inc., a Delaware corporation ("Buyer"). Capitalized terms used and not otherwise defined herein shall have the respective meanings assigned to them in the Merger Agreement referred to below.
